Your session is about to expire
What is Videx
Approved as Treatment by the FDA
Didanosine, commonly known as Videx, is approved by the FDA for 1 uses including HIV .Effectiveness
When to interrupt dosage
The advised measure of Videx is contingent upon the determined condition, such as Urinary Tract Infection (UTI), Hand Hygiene and ethylene glycol. The quantity of dosage fluctuates depending on the methodology of delivery (e.g. Topical or Solution, gel forming / drops) set forth in the accompanying table.Warnings
There are 20 known major drug interactions with Videx.Videx Novel Uses: Which Conditions Have a Clinical Trial Featuring Videx?
32 active clinical trials are currently assessing the potential of Videx to address Obstructive Hypertrophic Cardiomyopathy, Urinary Tract Infection (UTI) and Disinfection-related issues.Patient Q&A Section about videx
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Can I fill Schengen visa form online?
"Please have your valid identity card or passport as well as travel documents ready before starting to fill out the online visa application form."
What is Videx form German visa?
"Welcome to VIDEX, the online application system for Schengen visas for the Federal Republic of Germany. This guide will provide you with all the information you need to know in order to use VIDEX and submit your application easily."
How do you complete a Videx form?
"Personal Details
Family Name - Applicant's surname as per passport bio details. (NOTE: In case there is only Given Name in the passport, same needs to be entered in both.) Name at birth - Do not write anything here. Country of birth - Depends on place of birth of applicant."
What is Videx used for?
"Videx (didanosine), also known as ddI, is indicated for the treatment of human immunodeficiency virus (HIV)-1 infection in combination with other antiretroviral agents [see Clinical Studies]. Videx should be taken on an empty stomach, at least 30 minutes before or 2 hours after eating."